Agendia has a total of 63 patents globally, out of which 24 have been granted. Of these 63 patents, more than 47% patents are active. United States Of America is where Agendia has filed the maximum number of patents, followed by Europe and Germany. Parallelly, Europe seems to be the main focused R&D center and is also the origin country of Agendia.
Agendia was founded in 2003. Agendia provides molecular diagnostic services. The Company offers discovery, development, and commercialization of products for the diagnosis of breast and colon cancer. Agendia serves patients worldwide. Agendia provides their services globally. As of April 2022 Charles River Laboratories has a market valuation of $262 Million.
Do read about some of the most popular patents of Agendia which have been covered by us in this article and also you can find Agendia patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Agendia patent portfolio.
How many patents does the CEO of Agendia have?
The CEO, Mark Straley has 0 patents.
How many patents does Agendia have?
Agendia has a total of 63 patents globally. These patents belong to 26 unique patent families. Out of 63 patents, 30 patents are active.
How Many Patents did Agendia File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Agendia Applications Filed | Agendia Patents Granted |
| 2011 | 11 | – |
| 2012 | 1 | 2 |
| 2013 | 3 | – |
| 2014 | 5 | 4 |
| 2015 | 1 | 9 |
| 2016 | 4 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 2 |
| 2019 | – | 2 |
| 2020 | – | 2 |
| 2021 | 10 | – |
How many Agendia patents are Alive/Dead?
Worldwide Patents
How Many Patents did Agendia File in Different Countries?
Countries in which Agendia Filed Patents
| Country | Patents |
| United States Of America | 17 |
| Europe | 13 |
| Germany | 7 |
| Australia | 2 |
| Canada | 2 |
| Mexico | 1 |
| New Zealand | 1 |
| Austria | 1 |
| Japan | 1 |
| Spain | 1 |
Where are Research Centers of Agendia Patents Located?
10 Best Agendia Patents
US20150275306A1 is the most popular patent in the Agendia portfolio. It has received 25 citations so far from companies like Veracyte and Genomedx Biosciences.
Below is the list of 10 most cited patents of Agendia:
| Publication Number | Citation Count |
| US20150275306A1 | 25 |
| WO2008039071A2 | 20 |
| WO2008147205A1 | 15 |
| WO2014058317A1 | 12 |
| WO2009002175A1 | 12 |
| EP2202320A1 | 8 |
| EP2159291A1 | 7 |
| WO2010074573A1 | 7 |
| WO2010024677A1 | 6 |
| US10072301B2 | 3 |
What Percentage of Agendia US Patent Applications were Granted?
Agendia (Excluding its subsidiaries) has filed 16 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 5 have been granted leading to a grant rate of 50.00%.
Below are the key stats of Agendia patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Agendia?
| Law Firm | Total Applications | Success Rate |
| Hoffmann & Baron | 10 | 55.56% |
| Brown Rudnick | 5 | 0% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Agendia key innovation segments?